Search research articles
Contact Us
Filters
Showing results (51-60 of 146) with videos related to
Page
of 15
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 11, 2022
Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Edoardo Mannucci, Andrea Giaccari, Marco Gallo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
December 11, 2021
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials
Edoardo Mannucci, Marco Gallo, Basilio Pintaudi, et al.
Expert Review of Anticancer Therapy
|
October 10, 2017
Tyrosine kinase inhibitors rechallenge in solid tumors: a review of literature and a case description with lenvatinib in thyroid cancer
Francesco Felicetti, Alice Nervo, Alessandro Piovesan, et al.
Journal of Molecular Modeling
|
April 25, 2012
DFT study of the interaction between the conjugated fluorescein and dabcyl system, using fluorescene quenching method
Mónica Alvarado-González, Marco Gallo, Pablo Lopez-Albarran, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 20, 2019
Symptomatic Biliary Disorders During Lenvatinib Treatment for Thyroid Cancer: An Underestimated Problem
Alice Nervo, Alberto Ragni, Marco Gallo, et al.
G3 (Bethesda, Md.)
|
October 6, 2022
Transcriptome analysis of FOXO-dependent hypoxia gene expression identifies Hipk as a regulator of low oxygen tolerance in Drosophila
Kate Ding, Elizabeth C Barretto, Michael Johnston, et al.
Pharmacogenomics and Personalized Medicine
|
June 28, 2014
Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach
Antonio Ceriello, Marco Gallo, Riccardo Candido, et al.
Critical Reviews in Food Science and Nutrition
|
October 12, 2017
The management of neuroendocrine tumours: A nutritional viewpoint
Marco Gallo, Giovanna Muscogiuri, Genoveffa Pizza, et al.
Chemical & Pharmaceutical Bulletin
|
January 7, 2014
De novo design of non-coordinating indolones as potential inhibitors for lanosterol 14-α-demethylase (CYP51)
Rodolfo González-Chávez, Roberto Martínez, María Eugenia Torre-Bouscoulet, et al.
Cardiovascular Diabetology
|
June 1, 2013
Management of hyperglycemia in type 2 diabetes: evidence and uncertainty
Katherine Esposito, Sandro Gentile, Riccardo Candido, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 146) with videos related to
Sort By:
Page
of 15
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
February 11, 2022
Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Edoardo Mannucci, Andrea Giaccari, Marco Gallo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
December 11, 2021
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials
Edoardo Mannucci, Marco Gallo, Basilio Pintaudi, et al.
Expert Review of Anticancer Therapy
|
October 10, 2017
Tyrosine kinase inhibitors rechallenge in solid tumors: a review of literature and a case description with lenvatinib in thyroid cancer
Francesco Felicetti, Alice Nervo, Alessandro Piovesan, et al.
Journal of Molecular Modeling
|
April 25, 2012
DFT study of the interaction between the conjugated fluorescein and dabcyl system, using fluorescene quenching method
Mónica Alvarado-González, Marco Gallo, Pablo Lopez-Albarran, et al.
Thyroid : Official Journal of the American Thyroid Association
|
December 20, 2019
Symptomatic Biliary Disorders During Lenvatinib Treatment for Thyroid Cancer: An Underestimated Problem
Alice Nervo, Alberto Ragni, Marco Gallo, et al.
G3 (Bethesda, Md.)
|
October 6, 2022
Transcriptome analysis of FOXO-dependent hypoxia gene expression identifies Hipk as a regulator of low oxygen tolerance in Drosophila
Kate Ding, Elizabeth C Barretto, Michael Johnston, et al.
Pharmacogenomics and Personalized Medicine
|
June 28, 2014
Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach
Antonio Ceriello, Marco Gallo, Riccardo Candido, et al.
Critical Reviews in Food Science and Nutrition
|
October 12, 2017
The management of neuroendocrine tumours: A nutritional viewpoint
Marco Gallo, Giovanna Muscogiuri, Genoveffa Pizza, et al.
Chemical & Pharmaceutical Bulletin
|
January 7, 2014
De novo design of non-coordinating indolones as potential inhibitors for lanosterol 14-α-demethylase (CYP51)
Rodolfo González-Chávez, Roberto Martínez, María Eugenia Torre-Bouscoulet, et al.
Cardiovascular Diabetology
|
June 1, 2013
Management of hyperglycemia in type 2 diabetes: evidence and uncertainty
Katherine Esposito, Sandro Gentile, Riccardo Candido, et al.
Page
of 15